cph:lun
|
4589
|
Apr 21st, 2024 12:00AM
|
Lundbeck
|
213K
|
5725
|
Open
|
|
Apr 21st, 2024 09:38AM
|
Apr 21st, 2024 09:38AM
|
Lundbeck is a biopharmaceutical company focused exclusively on neuroscience. We discover, develop, and commercialize treatments that improve the lives of people affected by neurological and psychiatric diseases.
As a focused innovator, we strive for our research and development programs to tackle some of the most complex challenges. We develop transformative medicines targeting people for whom there are few, if any, treatment options.
We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination against people living with brain diseases.
|
Open
|
Neuroscience research, Schizophrenia, Psychosis, Parkinson's disease, Alzheimer's disease, Depression, Mental Health, Psychiatry, Neurology, Brain Health, Migraine, and Brain Disease
|
Open
|
H. Lundbeck, Ottiliavej 9
|
Valby
|
Copenhagen
|
DK
|
2500
|
|
Lundbeck A/S
|
Health Care
|
Pharmaceuticals & Biotechnology
|
cph:lun
|
4589
|
Apr 20th, 2024 12:00AM
|
Lundbeck
|
213K
|
5725
|
Open
|
|
Apr 20th, 2024 08:36AM
|
Apr 21st, 2024 03:54AM
|
Lundbeck is a biopharmaceutical company focused exclusively on neuroscience. We discover, develop, and commercialize treatments that improve the lives of people affected by neurological and psychiatric diseases.
As a focused innovator, we strive for our research and development programs to tackle some of the most complex challenges. We develop transformative medicines targeting people for whom there are few, if any, treatment options.
We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination against people living with brain diseases.
|
Open
|
Neuroscience research, Schizophrenia, Psychosis, Parkinson's disease, Alzheimer's disease, Depression, Mental Health, Psychiatry, Neurology, Brain Health, Migraine, and Brain Disease
|
Open
|
H. Lundbeck, Ottiliavej 9
|
Valby
|
Copenhagen
|
DK
|
2500
|
|
Lundbeck A/S
|
Health Care
|
Pharmaceuticals & Biotechnology
|
cph:lun
|
4589
|
Apr 19th, 2024 12:00AM
|
Lundbeck
|
213K
|
5726
|
Open
|
|
Apr 19th, 2024 11:12AM
|
Apr 19th, 2024 11:12AM
|
Lundbeck is a biopharmaceutical company focused exclusively on neuroscience. We discover, develop, and commercialize treatments that improve the lives of people affected by neurological and psychiatric diseases.
As a focused innovator, we strive for our research and development programs to tackle some of the most complex challenges. We develop transformative medicines targeting people for whom there are few, if any, treatment options.
We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination against people living with brain diseases.
|
Open
|
Neuroscience research, Schizophrenia, Psychosis, Parkinson's disease, Alzheimer's disease, Depression, Mental Health, Psychiatry, Neurology, Brain Health, Migraine, and Brain Disease
|
Open
|
H. Lundbeck, Ottiliavej 9
|
Valby
|
Copenhagen
|
DK
|
2500
|
|
Lundbeck A/S
|
Health Care
|
Pharmaceuticals & Biotechnology
|
cph:lun
|
4589
|
Apr 18th, 2024 12:00AM
|
Lundbeck
|
213K
|
5724
|
Open
|
|
Apr 18th, 2024 09:49AM
|
Apr 19th, 2024 07:36AM
|
Lundbeck is a biopharmaceutical company focused exclusively on neuroscience. We discover, develop, and commercialize treatments that improve the lives of people affected by neurological and psychiatric diseases.
As a focused innovator, we strive for our research and development programs to tackle some of the most complex challenges. We develop transformative medicines targeting people for whom there are few, if any, treatment options.
We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination against people living with brain diseases.
|
Open
|
Neuroscience research, Schizophrenia, Psychosis, Parkinson's disease, Alzheimer's disease, Depression, Mental Health, Psychiatry, Neurology, Brain Health, Migraine, and Brain Disease
|
Open
|
H. Lundbeck, Ottiliavej 9
|
Valby
|
Copenhagen
|
DK
|
2500
|
|
Lundbeck A/S
|
Health Care
|
Pharmaceuticals & Biotechnology
|
cph:lun
|
4589
|
Apr 17th, 2024 12:00AM
|
Lundbeck
|
213K
|
5729
|
Open
|
|
Apr 17th, 2024 11:11AM
|
Apr 17th, 2024 09:51PM
|
Lundbeck is a biopharmaceutical company focused exclusively on neuroscience. We discover, develop, and commercialize treatments that improve the lives of people affected by neurological and psychiatric diseases.
As a focused innovator, we strive for our research and development programs to tackle some of the most complex challenges. We develop transformative medicines targeting people for whom there are few, if any, treatment options.
We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination against people living with brain diseases.
|
Open
|
Neuroscience research, Schizophrenia, Psychosis, Parkinson's disease, Alzheimer's disease, Depression, Mental Health, Psychiatry, Neurology, Brain Health, Migraine, and Brain Disease
|
Open
|
H. Lundbeck, Ottiliavej 9
|
Valby
|
Copenhagen
|
DK
|
2500
|
|
Lundbeck A/S
|
Health Care
|
Pharmaceuticals & Biotechnology
|
cph:lun
|
4589
|
Apr 16th, 2024 12:00AM
|
Lundbeck
|
213K
|
5728
|
Open
|
|
Apr 16th, 2024 08:48AM
|
Apr 16th, 2024 06:08PM
|
Lundbeck is a biopharmaceutical company focused exclusively on neuroscience. We discover, develop, and commercialize treatments that improve the lives of people affected by neurological and psychiatric diseases.
As a focused innovator, we strive for our research and development programs to tackle some of the most complex challenges. We develop transformative medicines targeting people for whom there are few, if any, treatment options.
We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination against people living with brain diseases.
|
Open
|
Neuroscience research, Schizophrenia, Psychosis, Parkinson's disease, Alzheimer's disease, Depression, Mental Health, Psychiatry, Neurology, Brain Health, Migraine, and Brain Disease
|
Open
|
H. Lundbeck, Ottiliavej 9
|
Valby
|
Copenhagen
|
DK
|
2500
|
|
Lundbeck A/S
|
Health Care
|
Pharmaceuticals & Biotechnology
|
cph:lun
|
4589
|
Apr 15th, 2024 12:00AM
|
Lundbeck
|
213K
|
5728
|
Open
|
|
Apr 15th, 2024 11:31AM
|
Apr 16th, 2024 05:38AM
|
Lundbeck is a biopharmaceutical company focused exclusively on neuroscience. We discover, develop, and commercialize treatments that improve the lives of people affected by neurological and psychiatric diseases.
As a focused innovator, we strive for our research and development programs to tackle some of the most complex challenges. We develop transformative medicines targeting people for whom there are few, if any, treatment options.
We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination against people living with brain diseases.
|
Open
|
Neuroscience research, Schizophrenia, Psychosis, Parkinson's disease, Alzheimer's disease, Depression, Mental Health, Psychiatry, Neurology, Brain Health, Migraine, and Brain Disease
|
Open
|
H. Lundbeck, Ottiliavej 9
|
Valby
|
Copenhagen
|
DK
|
2500
|
|
Lundbeck A/S
|
Health Care
|
Pharmaceuticals & Biotechnology
|
cph:lun
|
4589
|
Apr 14th, 2024 12:00AM
|
Lundbeck
|
212K
|
5725
|
Open
|
|
Apr 14th, 2024 07:32AM
|
Apr 14th, 2024 07:32AM
|
Lundbeck is a biopharmaceutical company focused exclusively on neuroscience. We discover, develop, and commercialize treatments that improve the lives of people affected by neurological and psychiatric diseases.
As a focused innovator, we strive for our research and development programs to tackle some of the most complex challenges. We develop transformative medicines targeting people for whom there are few, if any, treatment options.
We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination against people living with brain diseases.
|
Open
|
Neuroscience research, Schizophrenia, Psychosis, Parkinson's disease, Alzheimer's disease, Depression, Mental Health, Psychiatry, Neurology, Brain Health, Migraine, and Brain Disease
|
Open
|
H. Lundbeck, Ottiliavej 9
|
Valby
|
Copenhagen
|
DK
|
2500
|
|
Lundbeck A/S
|
Health Care
|
Pharmaceuticals & Biotechnology
|
cph:lun
|
4589
|
Apr 13th, 2024 12:00AM
|
Lundbeck
|
212K
|
5726
|
Open
|
|
Apr 13th, 2024 06:24AM
|
Apr 13th, 2024 06:24PM
|
Lundbeck is a biopharmaceutical company focused exclusively on neuroscience. We discover, develop, and commercialize treatments that improve the lives of people affected by neurological and psychiatric diseases.
As a focused innovator, we strive for our research and development programs to tackle some of the most complex challenges. We develop transformative medicines targeting people for whom there are few, if any, treatment options.
We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination against people living with brain diseases.
|
Open
|
Neuroscience research, Schizophrenia, Psychosis, Parkinson's disease, Alzheimer's disease, Depression, Mental Health, Psychiatry, Neurology, Brain Health, Migraine, and Brain Disease
|
Open
|
H. Lundbeck, Ottiliavej 9
|
Valby
|
Copenhagen
|
DK
|
2500
|
|
Lundbeck A/S
|
Health Care
|
Pharmaceuticals & Biotechnology
|
cph:lun
|
4589
|
Apr 12th, 2024 12:00AM
|
Lundbeck
|
212K
|
5724
|
Open
|
|
Apr 12th, 2024 06:39AM
|
Apr 12th, 2024 03:37PM
|
Lundbeck is a biopharmaceutical company focused exclusively on neuroscience. We discover, develop, and commercialize treatments that improve the lives of people affected by neurological and psychiatric diseases.
As a focused innovator, we strive for our research and development programs to tackle some of the most complex challenges. We develop transformative medicines targeting people for whom there are few, if any, treatment options.
We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination against people living with brain diseases.
|
Open
|
Neuroscience research, Schizophrenia, Psychosis, Parkinson's disease, Alzheimer's disease, Depression, Mental Health, Psychiatry, Neurology, Brain Health, Migraine, and Brain Disease
|
Open
|
H. Lundbeck, Ottiliavej 9
|
Valby
|
Copenhagen
|
DK
|
2500
|
|
Lundbeck A/S
|
Health Care
|
Pharmaceuticals & Biotechnology
|